Epstein Secrets

Gates Catalyst 3 (bgc3), Bill Gates Ventures (BGV) and at the Bill & Melinda Gates Foundation (BMGF). Boris has led investment activities at these Gates-affiliated organizations on both the for-profit and non-for-profit aspects of Bill Gates' activities. On the for-profit side, Boris led investments

t hard-to-drug targets. Nimbus Discovery harnesses cutting-edge computational technologies to uncover breakthroughs in small molecule pharmacology. Nimbus focuses on medically important and highly sought-after disease targets that have proven inaccessible to traditional industry approaches. Nimbus' rob

the for-profit side, Boris led investments in various life science/health care companies such as Foundation Medicine, Research Gate, Schrodinger and Nimbus through Bill Gates Ventures. On the non-for profit side, Boris co-managed BMGF's $1.5 billion strategic investment pool focused on program-related

BMGF in October 2007 and bgC3 in April 2010. Dr. Nikolic has led select for-profit and not-for-profit investment activities at the aforementioned Gates-affiliated organizations. On the for-profit side, Dr. Nikolic has led investments in various life- science/IT/healthcare companies such as Foundation

life- science/IT/healthcare companies such as Foundation Medicine and Research Gate, served on the board of directors of Schrodinger, and monitored Nimbus. On the not-for-profit side, Dr. Nikolic co- managed BMGF's $1.5 billion strategic-investment pool, focused on program-related investments in health

ed and a full discussion followed. Mr. Friesner summarized his conversation with Bill Gates in December 2013 on a possible future financing by Mr. Gates. Mr. Guidero stated he would consult with Mr. Gates regarding the potential financing. The Board agreed to address the issue of whether additional

ined by Nimbus Discovery, LLC ("Nimbus") in mid-January 2014. Ms. Tran informed the Board that (i) the bridge investors' equity would sit on top of Nimbus' existing investors' equity such that the bridge investors would be paid out in the event of a distribution of proceeds by Nimbus and that (ii) the